ClariVest Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

ClariVest Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-162	Closed	–	–	775
2022 Q2	$0	Sell	162 -12,000	-99%	-$20.7K	﹤0.01%	805
2022 Q1	$28K	Sell	12,162 -53,502	-81%	-$167K	﹤0.01%	454
2021 Q4	$306K	Sell	65,664 -3,197	-5%	-$19.8K	0.01%	465
2021 Q3	$526K	Sell	68,861 -2,368	-3%	-$20.1K	0.02%	433
2021 Q2	$691K	Sell	71,229 -58,835	-45%	-$469K	0.02%	372
2021 Q1	$1.07M	Buy	130,064 +8,862	+7%	+$93.6K	0.04%	276
2020 Q4	$828K	Sell	121,202 -75,553	-38%	-$607K	0.03%	296
2020 Q3	$2.19M	Buy	+196,755	New	+$1.8M	0.07%	209

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

ClariVest Asset Management's SRNE Position: Q3 2022 in Review

ClariVest Asset Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 162 shares.

ClariVest Asset Management first reported a position in SRNE in Q3 2020 and held it in 8 quarters. The position peaked at $2.19M in Q3 2020. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

ClariVest Asset Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
ClariVest Asset Management sold 162 Sorrento Therapeutics, Inc. shares in Q3 2022.
ClariVest Asset Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 8 quarters.
ClariVest Asset Management's Sorrento Therapeutics, Inc. position peaked at $2.19M in Q3 2020.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.